JP2024522135A5 - - Google Patents
Info
- Publication number
- JP2024522135A5 JP2024522135A5 JP2023574275A JP2023574275A JP2024522135A5 JP 2024522135 A5 JP2024522135 A5 JP 2024522135A5 JP 2023574275 A JP2023574275 A JP 2023574275A JP 2023574275 A JP2023574275 A JP 2023574275A JP 2024522135 A5 JP2024522135 A5 JP 2024522135A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- salt
- use according
- tgf
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2108245.8 | 2021-06-09 | ||
| GBGB2108245.8A GB202108245D0 (en) | 2021-06-09 | 2021-06-09 | Methods of treatment |
| PCT/EP2022/065562 WO2022258693A1 (en) | 2021-06-09 | 2022-06-08 | Autotaxin (atx) inhibitor for the treatment of pancreatic cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024522135A JP2024522135A (ja) | 2024-06-11 |
| JP2024522135A5 true JP2024522135A5 (https=) | 2025-06-16 |
Family
ID=76838834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023574275A Pending JP2024522135A (ja) | 2021-06-09 | 2022-06-08 | 膵臓癌の治療のためのオートタキシン（ａｔｘ）阻害剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250057820A1 (https=) |
| EP (1) | EP4351563A1 (https=) |
| JP (1) | JP2024522135A (https=) |
| CN (1) | CN117295496A (https=) |
| AU (1) | AU2022290378A1 (https=) |
| CA (1) | CA3218103A1 (https=) |
| GB (1) | GB202108245D0 (https=) |
| MX (1) | MX2023014637A (https=) |
| WO (1) | WO2022258693A1 (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201502020D0 (en) * | 2015-02-06 | 2015-03-25 | Cancer Rec Tech Ltd | Autotaxin inhibitory compounds |
| JP2024511836A (ja) * | 2021-03-29 | 2024-03-15 | アイオンクチュラ・ソシエテ・アノニム | 膵臓癌の治療のためのｐｉ３ｋ－デルタ阻害剤 |
-
2021
- 2021-06-09 GB GBGB2108245.8A patent/GB202108245D0/en not_active Ceased
-
2022
- 2022-06-08 CN CN202280032188.0A patent/CN117295496A/zh active Pending
- 2022-06-08 MX MX2023014637A patent/MX2023014637A/es unknown
- 2022-06-08 CA CA3218103A patent/CA3218103A1/en active Pending
- 2022-06-08 JP JP2023574275A patent/JP2024522135A/ja active Pending
- 2022-06-08 US US18/567,932 patent/US20250057820A1/en active Pending
- 2022-06-08 EP EP22734239.1A patent/EP4351563A1/en active Pending
- 2022-06-08 WO PCT/EP2022/065562 patent/WO2022258693A1/en not_active Ceased
- 2022-06-08 AU AU2022290378A patent/AU2022290378A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022121594A5 (https=) | ||
| JP2021063088A5 (https=) | ||
| JP2022537551A5 (https=) | ||
| JP2025065389A (ja) | 化合物の製剤およびそれらの使用 | |
| JP2004525142A5 (https=) | ||
| JP2024540183A5 (https=) | ||
| JP2022553954A5 (https=) | ||
| JP2020512337A5 (https=) | ||
| CN107296811A (zh) | 一种用于治疗胃癌的喹啉衍生物 | |
| JP2024519845A5 (https=) | ||
| JP2024511836A5 (https=) | ||
| JP2015517523A5 (https=) | ||
| JP2022532766A5 (https=) | ||
| JP2023553533A5 (https=) | ||
| JP2025013684A (ja) | 重度腎機能障害を有する癌患者に対する治療方法 | |
| JP2024531188A5 (https=) | ||
| JP2022551691A5 (https=) | ||
| JP2025502064A5 (https=) | ||
| JP2022534118A5 (https=) | ||
| JP2002544227A5 (https=) | ||
| JP3208437B2 (ja) | 癌転移抑制剤 | |
| JP2023531675A5 (https=) | ||
| CN101610776A (zh) | 包含CNDAC(2′-氰基-2′-脱氧-N4 -棕榈酰基-1-β-D-阿拉伯呋喃糖基-胞嘧啶)和细胞毒剂的组合 | |
| JP2022544559A5 (https=) | ||
| JP2024522135A5 (https=) |